Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
European Organisation for Research and Treatment of Cancer · European Organisation for Research and Treatment of Cancer · +7 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,972
total citations
- FWCI
- 77.08
- Percentile
- 100%
- References
- 58
Citations per year
Authors
8- RSRichard SylvesterCorresponding
European Organisation for Research and Treatment of Cancer, European Organisation for Research and Treatment of Cancer
- APAdrian P.M. van der Meijden
Jeroen Bosch Ziekenhuis
- WOWillem Oosterlinck
Ghent University Hospital
- JAJ. Alfred Witjes
Radboud University Nijmegen, Radboud University Medical Center
- CBC Bouffioux
Centre Hospitalier Universitaire de Liège
Topics & keywords
Topics
Keywords
- Medicine
- Stage (stratigraphy)
- Pathological
- Cancer recurrence
- Carcinoma in situ
- Bladder cancer
- Cancer
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.